Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Cediranib plus chemotherapy showed no clear difference in overall survival compared with placebo plus chemotherapy (low certainty).
It is very uncertain whether cediranib plus chemotherapy changes specific adverse events: gastrointestinal perforations or fistulae compared with placebo plus chemotherapy (very low certainty).
The review found no eligible studies for this question.
Postsurgical medical therapy may leads to lower disease recurrence ≤ 12 months (dichotomous) compared with placebo or no medical therapy (low certainty).
It is very uncertain whether postsurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).
Postsurgical medical therapy probably leads to higher pregnancy rate (dichotomous) compared with placebo or no medical therapy (moderate certainty).
The review found no eligible studies for this question.
Presurgical medical therapy showed no clear difference in pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with postsurgical medical therapy (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether presurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with postsurgical medical therapy (very low certainty).
It is very uncertain whether presurgical medical therapy changes pregnancy rate (dichotomous) compared with postsurgical medical therapy (very low certainty).
It is very uncertain whether presurgical medical therapy changes pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether presurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).
It is very uncertain whether presurgical medical therapy changes pregnancy rate (dichotomous) compared with placebo or no medical therapy (very low certainty).
Postsurgical medical therapy may leads to lower pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (low certainty).